ERAS logo

ERAS
Erasca Inc

1,000
Mkt Cap
$3.46B
Volume
3.11M
52W High
$24.28
52W Low
$1.06
PE Ratio
-11.92
ERAS Fundamentals
Price
$11.61
Prev Close
$11.12
Open
$11.10
50D MA
$14.67
Beta
1.40
Avg. Volume
9.91M
EPS (Annual)
-$0.4393
P/B
8.78
Rev/Employee
$0.00
$825.81
Loading...
Loading...
News
all
press releases
Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset
Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions...
PR Newswire·10h ago
News Placeholder
More News
News Placeholder
ERAS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Erasca, Inc.
The law firm of Kirby McInerney LLP continues its investigation on behalf of Erasca, Inc. (Erasca or the Company) (NASDAQ:ERAS) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws and other unlawful business practices. [LEARN...
Business Wire·2d ago
News Placeholder
Erasca Stock Is Up 715%. Here's Why One Biotech Fund Still Bought $68 Million More
Erasca Stock Is Up 715%. Here's Why One Biotech Fund Still Bought $68 Million More...
Yahoo! Finance: News·4d ago
News Placeholder
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy...
Yahoo! Finance: News·5d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc...
PR Newswire·7d ago
News Placeholder
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700%
Key PointsNew York-based Siren bought 2,486,997 shares of Erasca in the first quarter; the estimated transaction value was $29.39 million based on average first-quarter 2026 prices...
Nasdaq News: Markets·7d ago
News Placeholder
ERASCA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Erasca, Inc. (Erasca or the Company) (NASDAQ:ERAS). The investigation concerns whether the Company and/or members of its...
Business Wire·9d ago
News Placeholder
JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels
JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels...
Yahoo! Finance: News·11d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc...
PR Newswire·14d ago
News Placeholder
Erasca, Inc. (NASDAQ:ERAS) Given Average Rating of "Moderate Buy" by Brokerages
Erasca, Inc. (NASDAQ:ERAS - Get Free Report) has been assigned an average recommendation of 'Moderate Buy' from the ten research firms that are presently covering the firm, MarketBeat.com reports...
MarketBeat·16d ago
<
1
2
...
>

Latest ERAS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.